Cargando...
Recent advances in antimultiple myeloma drug development
Multiple myeloma (MM) is the second most common hematological malignancy and is characterized by the aberrant proliferation of terminally differentiated plasma B cells with impairment in apoptosis capacity. Particularly, osteolytic bone diseases and renal failure resulting from hyperparaproteinemia...
Gardado en:
| Publicado en: | Pharm Pat Anal |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4465869/ https://ncbi.nlm.nih.gov/pubmed/24998287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/ppa.14.18 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|